Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study
This study demonstrated favorable visual and anatomic outcomes and safety profile for eyes with nAMD treated by IVI brolucizumab. Mean maximum injection-free interval in eyes treated with PRN was 19 weeks.
Authors
- Giridhar Anantharaman (ORCID: https://orcid.org/0000-0002-7126-4885)
- Shalini Sugumar
- Ramesh Chandra Tiwari (ORCID: https://orcid.org/0000-0001-5784-136X)
- Anubhav Goyal (ORCID: https://orcid.org/0000-0002-1364-2681)
- Daraius Shroff (ORCID: https://orcid.org/0000-0002-5708-604X)
- Rajiv Jain (ORCID: https://orcid.org/0000-0002-5322-9074)
- Raja Rami Reddy (ORCID: https://orcid.org/0000-0003-3799-6377)
- Aniruddha Agarwal (ORCID: https://orcid.org/0000-0003-4985-9855)
- Ramesh Venkatesh (ORCID: https://orcid.org/0000-0002-4479-9390)
- Shashank Gupta (ORCID: https://orcid.org/0000-0002-2124-9388)
- Deependra Vikram Singh (ORCID: https://orcid.org/0000-0001-9419-1415)
- Charu Gupta (ORCID: https://orcid.org/0000-0002-8908-4911)
- Jatinder Singh (ORCID: https://orcid.org/0000-0001-9073-0979)
- Prashant Bawankule (ORCID: https://orcid.org/0000-0001-6063-8485)
- Shilpi H. Narnaware (ORCID: https://orcid.org/0000-0003-3170-955X)
- Sanjiv Choudhary (ORCID: https://orcid.org/0000-0002-6634-4880)
- Aishwarya Joshi (ORCID: https://orcid.org/0000-0001-9739-4496)
- Ritesh Narula (ORCID: https://orcid.org/0000-0003-0192-0178)
- Pradeep Kumar
- Shrinivas Joshi
Institutions
- Sankara Nethralaya (IN)
- Aravind Eye Hospital (IN)
- L V Prasad Eye Institute (IN)
- Joshi Hospital (IN)
- Maastricht University (NL)
- Cleveland Clinic Lerner College of Medicine (US)
- Narayana Nethralaya (IN)
- Chaithanya Eye Hospital and Research Institute (IN)
- Dr. Shroff’s Charity Eye Hospital (IN)
- Nethradhama Superspeciality Eye Hospital (IN)
- Vasan Eye Care Hospital (IN)
- Centre for Sight (IN)
- Army Hospital Research and Referral (IN)
Publication Details
- Journal
- Indian Journal of Ophthalmology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.4103/ijo.ijo_757_24
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54